{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:32Z","timestamp":1792800032214,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["1012358"],"award-info":[{"award-number":["1012358"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer Society","doi-asserted-by":"publisher","award":["15-17"],"award-info":[{"award-number":["15-17"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jagp.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:34:19Z","timestamp":1557336859000},"page":"1161-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"title":["Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Nathan","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myuri","family":"Ruthirakuhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas Paul L.G.","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2019.05.002_bib0001","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(05)70219-2","article-title":"Behavioural changes and psychological symptoms in dementia disorders","volume":"4","author":"McKeith","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F","article-title":"Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments","volume":"16","author":"Margallo-Lana","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1503\/cmaj.070804","article-title":"Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease","volume":"179","author":"Herrmann","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.jagp.2019.05.002_bib0004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and meta-analysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2019.05.002_bib0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2190\/ABXK-FMWG-98YP-D1CU","article-title":"The consequences of non-cognitive symptoms of dementia in medical hospital departments","volume":"33","author":"Wancata","year":"2003","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.jagp.2019.05.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003476.pub2","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jagp.2019.05.002_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1545109707300157","article-title":"Use of dronabinol improves appetite and reverses weight loss in HIV\/AIDS-infected patients","volume":"6","author":"DeJesus","year":"2007","journal-title":"J Int Assoc Physicians AIDS Care"},{"key":"10.1016\/j.jagp.2019.05.002_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0009","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(03)00163-5","article-title":"The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions","volume":"105","author":"Naef","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jagp.2019.05.002_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0011","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0019-5545.86796","article-title":"Cannabis use and cognitive dysfunction","volume":"53","author":"Shrivastava","year":"2011","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0012","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","article-title":"Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial","volume":"84","author":"van den Elsen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jagp.2015.07.011","article-title":"Tetrahydrocannabinol in behavioral disturbances in dementia: a crossover randomized controlled trial","volume":"23","author":"van den Elsen","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0014","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.wad.0000137520.23370.56","article-title":"Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators","volume":"18","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2019.05.002_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000417403","article-title":"Agitation in the elderly","volume":"19","author":"Cohen-Mansfield","year":"1989","journal-title":"Adv Psychosom Med"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2019.05.002_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1041610297004754","article-title":"A guide to the standardized mini-mental state examination","volume":"9","author":"Molloy","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2019.05.002_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archneur.1994.00540130067012","article-title":"Severe impairment battery. a neuropsychological test for severely demented patients","volume":"51","author":"Panisset","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1041610297004298","article-title":"Alzheimer's disease assessment scale: reliability and validity in a multicenter clinical trial","volume":"9","author":"Weyer","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2019.05.002_bib0019","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.05.002_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1041610214001963","article-title":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition","volume":"27","author":"Cummings","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2019.05.002_bib0021","doi-asserted-by":"crossref","unstructured":"Guy W: Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology\u2014Revised 1976; 218-222","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.jagp.2019.05.002_bib0022","doi-asserted-by":"crossref","first-page":"M366","DOI":"10.1093\/gerona\/56.6.M366","article-title":"Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF)","volume":"56","author":"Rubenstein","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jagp.2019.05.002_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.JAM.0000043422.31640.F7","article-title":"Development and psychometric evaluation of the pain assessment in advanced dementia (PAINAD) scale","volume":"4","author":"Warden","year":"2003","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2019.05.002_bib0024","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/gps.636","article-title":"Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease","volume":"17","author":"Lanctot","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0026","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000097757","article-title":"A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease","volume":"23","author":"Herrmann","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2019.05.002_bib0027","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0269881104042625","article-title":"Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients","volume":"18","author":"Herrmann","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0028","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jagp.2019.05.002_bib0029","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.1885","article-title":"Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis","volume":"23","author":"Deberdt","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2019.05.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008191.pub2","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jagp.2019.05.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004990","article-title":"Trazodone for agitation in dementia","author":"Martinon-Torres","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jagp.2019.05.002_bib0033","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2019.05.002_bib0034","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00002093-199700112-00008","article-title":"The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's disease cooperative study","volume":"11","author":"Schmitt","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2019.05.002_bib0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cns.12158","article-title":"A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg\/24 h versus 4.6 mg\/24 h in severe Alzheimer's dementia","volume":"19","author":"Farlow","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jagp.2019.05.002_bib0036","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/01.wnl.0000266627.96040.5a","article-title":"Donepezil preserves cognition and global function in patients with severe Alzheimer disease","volume":"69","author":"Black","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.05.002_bib0037","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/00019442-200511000-00011","article-title":"Development of a short form of the severe impairment battery","volume":"13","author":"Saxton","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0038","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1464-410X.1989.tb05140.x","article-title":"Another approach to the treatment of priapism","volume":"63","author":"Forsberg","year":"1989","journal-title":"Br J Urol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0039","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jagp.2012.11.022","article-title":"Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms","volume":"22","author":"Woodward","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jagp.2019.05.002_bib0041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0042","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1369-1600.2011.00427.x","article-title":"Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers","volume":"18","author":"Bedi","year":"2013","journal-title":"Addict Biol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0043","doi-asserted-by":"crossref","first-page":"301","DOI":"10.9758\/cpn.2017.15.4.301","article-title":"A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders","volume":"15","author":"Lim","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.jagp.2019.05.002_bib0044","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.jagp.2019.05.002_bib0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/TCRM.S126849","article-title":"Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer","volume":"14","author":"Badowski","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jagp.2019.05.002_bib0046","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"Ravinet Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jagp.2019.05.002_bib0047","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01639360802265939","article-title":"Weight loss and nutritional considerations in Alzheimer disease","volume":"27","author":"Smith","year":"2008","journal-title":"J Nutr Elder"},{"key":"10.1016\/j.jagp.2019.05.002_bib0048","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J052v25n03_07","article-title":"Improving nutrition care for nursing home residents using the INRx process","volume":"25","author":"Crogan","year":"2006","journal-title":"J Nutr Elder"},{"key":"10.1016\/j.jagp.2019.05.002_bib0049","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1532-5415.2004.52464.x","article-title":"Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study","volume":"52","author":"Lauque","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2019.05.002_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000468923","article-title":"Associations between pain and quality of life in severe dementia: a Norwegian cross-sectional study","volume":"7","author":"Rostad","year":"2017","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jagp.2019.05.002_bib0051","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/AJP.0b013e31802be869","article-title":"An interdisciplinary expert consensus statement on assessment of pain in older persons","volume":"23","author":"Hadjistavropoulos","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jagp.2019.05.002_bib0052","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1532-5415.2004.52063.x","article-title":"Is chronic nonmalignant pain associated with decreased appetite in older adults? Preliminary evidence","volume":"52","author":"Bosley","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2019.05.002_bib0053","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/gps.2649","article-title":"Pain treatment of agitation in patients with dementia: a systematic review","volume":"26","author":"Husebo","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.05.002_bib0054","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2125.2010.03847.x","article-title":"Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment","volume":"71","author":"McLachlan","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jagp.2019.05.002_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.jagp.2019.05.002_bib0056","series-title":"The Pain Assessment in Advanced Dementia Scale (PAINAD) Brief","author":"Herr","year":"2004"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119303550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119303550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:28:12Z","timestamp":1761020892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748119303550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1064748119303550"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2019.05.002","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.","name":"copyright","label":"Copyright"}]}}